Su Zeng
Impact in
- Pharmaceutical Science top 0.2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Epigenetics and DNA Methylation 20
- RNA Interference and Gene Delivery 16
- Advanced biosensing and bioanalysis techniques 15
- Oncology 92
- Drug Transport and Resistance Mechanisms 78
- Co-authors
- Lushan Yu (102 shared papers)Fuqiang Hu (7 shared papers)Huidi Jiang (74 shared papers)Yongzhong Du (6 shared papers)Yu Kang (14 shared papers)Hong Yuan (5 shared papers)Haihong Hu (49 shared papers)Yi-Qing Ye (2 shared papers)
- Journals
- Drug Metabolism and Disposition (20 papers)Journal of Pharmaceutical and Biomedical Analysis (18 papers)Journal of Chromatography B (17 papers)Chirality (15 papers)International Journal of Pharmaceutics (12 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Su Zeng
382 papers receiving 9.7k citations
Su Zeng's Hit Papers
Peers
Comparison fields: 5 of 164
- Pharmaceutical Science 1.1k
- Pharmacology 1.4k
- Oncology 1.6k
- Complementary and alternative medicine 498
- Molecular Biology 3.9k
Countries citing papers authored by Su Zeng
This map shows the geographic impact of Su Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Zeng more than expected).
Fields of papers citing papers by Su Zeng
This network shows the impact of papers produced by Su Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Zeng. The network helps show where Su Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Su Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 450 | |
| 2 | 2020 | 377 | |
| 3 | The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents Hit paper breakdown → | 2020 | 328 |
| 4 | 2007 | 236 | |
| 5 | 2006 | 221 | |
| 6 | 2006 | 185 | |
| 7 | 2007 | 172 | |
| 8 | 2007 | 154 | |
| 9 | 2006 | 148 | |
| 10 | 2006 | 133 | |
| 11 | 2019 | 127 | |
| 12 | 2013 | 123 | |
| 13 | 2007 | 120 | |
| 14 | 2021 | 109 | |
| 15 | 2012 | 104 | |
| 16 | 2023 | 95 | |
| 17 | 2007 | 89 | |
| 18 | 2013 | 88 | |
| 19 | 2020 | 84 | |
| 20 | 2015 | 83 |
About Su Zeng
Su Zeng is a scholar working on Molecular Biology, Oncology, Pharmacology, Spectroscopy and Pharmacology, having authored 391 papers that have together received 9.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (78 papers), Pharmacogenetics and Drug Metabolism (65 papers), Analytical Chemistry and Chromatography (62 papers), Analytical Methods in Pharmaceuticals (21 papers), Epigenetics and DNA Methylation (20 papers), RNA Interference and Gene Delivery (16 papers), Ginkgo biloba and Cashew Applications (16 papers) and Advanced biosensing and bioanalysis techniques (15 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Pharmacology (1.4k citations), Oncology (1.6k citations), Complementary and alternative medicine (498 citations) and Molecular Biology (3.9k citations). Su Zeng has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Lushan Yu, Fuqiang Hu, Huidi Jiang, Yongzhong Du, Yu Kang, Hong Yuan, Haihong Hu, Yi-Qing Ye, Saiping Jiang and Tong-wei Yao. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmaceutical and Biomedical Analysis, Journal of Chromatography B, Chirality and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.